The celebrity investor has teamed up with a soft-spoken radiologist to tackle the USA’s healthcare crisis – and he has drug industry middlemen squarely in his sights.
In August 2015, a 32-year-old former hedge fund manager named Martin Shkreli bought the rights to a decades-old drug used to treat malaria and Aids complications and raised its price from $13.50 (£10.35) per pill to $750 per pill.